Skip to content

Potato Consumption and Energy Balance

Potato Consumption and Energy Balance: a Randomized, Controlled, Clinical Trial

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03518515
Enrollment
180
Registered
2018-05-08
Start date
2018-08-02
Completion date
2020-03-18
Last updated
2020-05-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Obesity

Keywords

nutrition intervention, potato consumption, energy balance

Brief summary

A randomized, clinical trial will be performed to assess changes in body weight and fat mass with daily potato consumption versus a calorie-matched snack of almonds.

Detailed description

This is a 30-day randomized, controlled trial with 3 arms: 1) non-potato food (almonds), 2) standard white potato French fry, 3) standard white potato French fry with potential glycemia-modulating spice/seasoning mix added. Free-living study participants will be assigned to consume one of the 3 foods (calorie matched) each day for a 30-day period. Body composition (via dual energy x-ray absorptiometry; DXA), and blood chemistry will be assayed at baseline and study completion, along with a sub-sample of subjects participating in a meal-based tolerance tests at study completion.

Interventions

OTHERWhite potato (french fries)

If randomized to this group, participants will be asked to consume 1 serving of French fries (\ 300 kcal) each day for 30 days as a part of their usual dietary intake. French fries will be portioned and provided to participants.

OTHERWhite potato (French fries), +seasoning

If randomized to this group, participants will be asked to consume 1 serving of French fries (\ 300 kcal) with added potential glycemia modifying seasoning mix each day for 30 days as a part of their usual dietary intake. French fries and seasoning will be portioned and provided to participants.

OTHERAlmond

If randomized to this group, participants will be asked to consume 1 serving of almonds that is calorically-matched to the French fries (\ 300 kcal) serving in the other arms each day for 30 days as a part of their usual dietary intake. Almonds will be portioned and provided to participants.

Sponsors

Alliance for Potato Research and Education
CollaboratorOTHER
Indiana University
CollaboratorOTHER
University of Alabama at Birmingham
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
BASIC_SCIENCE
Masking
SINGLE (Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to 50 Years
Healthy volunteers
Yes

Inclusion criteria

* 18- 50 years old * Body mass index (BMI) 20- 35 * No dietary restrictions or allergies * Weight stable * Access to camera through smartphone, computer or tablet

Exclusion criteria

* Pregnancy or anticipating pregnancy or lactation * Nut or food allergy * Diagnosed diabetes (Type 1 or 2) * History of weight control surgery (bariatric or liposuction) * Consumes \>1 serving of potatoes daily before enrollment * Weight loss or gain \>5% within past 6 months * Medical conditions or medications that would prevent the ability to comply with treatment assignment and/or affect energy balance * Dependence on others for food procurement or preparation

Design outcomes

Primary

MeasureTime frameDescription
Change in fat massbaseline and study completion (30 days)Determined by dual-energy X-ray absorptiometry.

Secondary

MeasureTime frameDescription
Change in fasting glucosebaseline and study completion (30 day)
Change in fasting insulinbaseline and study completion (30 day)
Change in body weightbaseline and study completion (30 day)
Change in caloric Intakebaseline and study completion (30 days)Dietary recall by 3 day food record.
Meal Tolerance TestStudy Completion (30 day)A subset of subjects from each diet group will participate in a meal-based tolerance test with the study food items.
Change in HbA1cbaseline and study completion (30 day)

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 18, 2026